125 related articles for article (PubMed ID: 30024105)
1. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.
Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D
Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer.
Zhong C; Wu K; Wang S; Long Z; Yang T; Zhong W; Tan X; Wang Z; Li C; Lu J; Mao X
Cell Death Dis; 2021 Jul; 12(8):726. PubMed ID: 34294687
[TBL] [Abstract][Full Text] [Related]
3. Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
Melbø-Jørgensen C; Ness N; Andersen S; Valkov A; Dønnem T; Al-Saad S; Kiselev Y; Berg T; Nordby Y; Bremnes RM; Busund LT; Richardsen E
PLoS One; 2014; 9(11):e113039. PubMed ID: 25401698
[TBL] [Abstract][Full Text] [Related]
4. A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Lv D; Wu X; Chen X; Yang S; Chen W; Wang M; Liu Y; Gu D; Zeng G
Cancer Immunol Immunother; 2021 Dec; 70(12):3587-3602. PubMed ID: 33934205
[TBL] [Abstract][Full Text] [Related]
5. Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.
Krzyzanowska A; Barron S; Higgins DF; Loughman T; O'Neill A; Sheehan KM; Wang CA; Fender B; McGuire L; Fay J; O'Grady A; O'Leary D; Watson RW; Bjartell A; Gallagher WM
Eur Urol Focus; 2023 Nov; 9(6):983-991. PubMed ID: 37105783
[TBL] [Abstract][Full Text] [Related]
6. A four gene signature predictive of recurrent prostate cancer.
Komisarof J; McCall M; Newman L; Bshara W; Mohler JL; Morrison C; Land H
Oncotarget; 2017 Jan; 8(2):3430-3440. PubMed ID: 27966447
[TBL] [Abstract][Full Text] [Related]
7. Effective Prediction of Prostate Cancer Recurrence through the
Gu Y; Lin X; Kapoor A; Li T; Major P; Tang D
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498739
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prostate cancer biochemical recurrence by using discretization supports the critical contribution of the extra-cellular matrix genes.
Marin L; Casado F
Sci Rep; 2023 Jun; 13(1):10144. PubMed ID: 37349324
[TBL] [Abstract][Full Text] [Related]
9. IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms.
Mei W; Dong Y; Gu Y; Kapoor A; Lin X; Su Y; Vega Neira S; Tang D
J Adv Res; 2023 Dec; 54():195-210. PubMed ID: 36681115
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence.
Lautert-Dutra W; Melo CM; Chaves LP; Souza FC; Crozier C; Sundby AE; Woroszchuk E; Saggioro FP; Avante FS; Dos Reis RB; Squire JA; Bayani J
Front Oncol; 2023; 13():1280943. PubMed ID: 37965470
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
Yang L; Roberts D; Takhar M; Erho N; Bibby BAS; Thiruthaneeswaran N; Bhandari V; Cheng WC; Haider S; McCorry AMB; McArt D; Jain S; Alshalalfa M; Ross A; Schaffer E; Den RB; Jeffrey Karnes R; Klein E; Hoskin PJ; Freedland SJ; Lamb AD; Neal DE; Buffa FM; Bristow RG; Boutros PC; Davicioni E; Choudhury A; West CML
EBioMedicine; 2018 May; 31():182-189. PubMed ID: 29729848
[TBL] [Abstract][Full Text] [Related]
12. Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database.
Boldrini L; Faviana P; Galli L; Paolieri F; Erba PA; Bardi M
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573332
[TBL] [Abstract][Full Text] [Related]
13. Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway.
Robsahm TE; Tsuruda KM; Hektoen HH; Storås AH; Cook MB; Hurwitz LM; Langseth H
Acta Oncol; 2023 Jan; 62(1):8-14. PubMed ID: 36762472
[TBL] [Abstract][Full Text] [Related]
14. Reference-free transcriptome signatures for prostate cancer prognosis.
Nguyen HTN; Xue H; Firlej V; Ponty Y; Gallopin M; Gautheret D
BMC Cancer; 2021 Apr; 21(1):394. PubMed ID: 33845808
[TBL] [Abstract][Full Text] [Related]
15. Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk.
Rasmussen M; Fredsøe J; Salachan PV; Blanke MPL; Larsen SH; Ulhøi BP; Jensen JB; Borre M; Sørensen KD
NPJ Precis Oncol; 2024 Feb; 8(1):48. PubMed ID: 38395986
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prostate cancer tissue metabolomics: would clinics utilise it for diagnosis?
Bansal N; Kumar M; Sankhwar SN; Gupta A
Expert Rev Mol Med; 2023 Aug; 25():e26. PubMed ID: 37548191
[TBL] [Abstract][Full Text] [Related]
17. Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.
Gu Y; Chow MJ; Kapoor A; Mei W; Jiang Y; Yan J; De Melo J; Seliman M; Yang H; Cutz JC; Bonert M; Major P; Tang D
Transl Oncol; 2018 Aug; 11(4):1012-1022. PubMed ID: 29966864
[TBL] [Abstract][Full Text] [Related]
18. Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.
Dunning MJ; Vowler SL; Lalonde E; Ross-Adams H; Boutros P; Mills IG; Lynch AG; Lamb AD
EBioMedicine; 2017 Mar; 17():5-6. PubMed ID: 28286059
[No Abstract] [Full Text] [Related]
19. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients.
An Y; Lu W; Li S; Lu X; Zhang Y; Han D; Su D; Jia J; Yuan J; Zhao B; Tu M; Li X; Wang X; Fang N; Ji S
Discov Oncol; 2023 Dec; 14(1):234. PubMed ID: 38112859
[TBL] [Abstract][Full Text] [Related]
20. SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.
Boysen G; Rodrigues DN; Rescigno P; Seed G; Dolling D; Riisnaes R; Crespo M; Zafeiriou Z; Sumanasuriya S; Bianchini D; Hunt J; Moloney D; Perez-Lopez R; Tunariu N; Miranda S; Figueiredo I; Ferreira A; Christova R; Gil V; Aziz S; Bertan C; de Oliveira FM; Atkin M; Clarke M; Goodall J; Sharp A; MacDonald T; Rubin MA; Yuan W; Barbieri CE; Carreira S; Mateo J; de Bono JS
Clin Cancer Res; 2018 Nov; 24(22):5585-5593. PubMed ID: 30068710
[No Abstract] [Full Text] [Related]
[Next] [New Search]